Close Menu
iM.NewsiM.News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 2026

    US Lawmakers Seek Stricter AI Chip Export Controls

    November 20, 2026

    TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

    November 20, 2026
    Facebook X (Twitter) Instagram
    iM.NewsiM.News
    Subscribe
    • Home
    • Lifestyle

      US, Mexico, Bolivia Lose Measles-Free Status as Global Cases Rise

      November 20, 2026

      The Opera Coat Trend Takes Over Winter Fashion

      November 20, 2026

      New Weight-Loss Drug Cuts Knee Pain in Half for OA Patients

      November 20, 2026

      Robert Pattinson and Suki Waterhouse Redefine Hollywood Power Couples

      November 20, 2026

      Reading Linked to 33% Lower Alzheimer’s Risk, Study Finds

      November 20, 2026
    • Relations

      US Lawmakers Seek Stricter AI Chip Export Controls

      November 20, 2026

      Trump Threatens Tax on US Tech Firms Building AI Data Centers Abroad

      November 20, 2026

      Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

      November 20, 2026

      Xi Jinping’s Restraint: The Power of Not Acting in Shenzhen

      November 20, 2026

      EU and UK to Sign Reset Deal on Trade and Youth Mobility

      November 20, 2026
    • Technology

      Germany Proposes €25 Billion Buyout of TikTok Europe

      November 20, 2026

      AI Supply Chain Leaks 2 Million Secrets in Canary Test

      November 20, 2026

      Google to retire Nest app in January 2027

      November 20, 2026

      Microsoft Link to Windows Adds Second Screen Feature

      November 20, 2026

      Nothing Sets December 8 Date for AI Hardware Reveal

      November 20, 2026
    • Travel & Tourism

      TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

      November 20, 2026

      Oil Spills Threaten UAE and Oman Beaches Amid Hormuz Conflict

      November 20, 2026

      Aer Lingus to Retrofit A330 Fleet with Premium Economy and New Business Class

      November 20, 2026

      Sabre Targets AI Travel Bookings With New Connector

      November 20, 2026

      Riyadh Hotel Revenue Plummets 65% After Airport Attack

      November 20, 2026
    • Get in Touch
    iM.NewsiM.News
    Home»Lifestyle»Health»Immunotherapy Prevents Bowel Cancer Recurrence in Trial
    Health

    Immunotherapy Prevents Bowel Cancer Recurrence in Trial

    im.newsBy im.newsOctober 10, 2026No Comments4 Mins Read13 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Laboratory equipment used for bowel cancer immunotherapy blood tests
    Photo: Unknown / Rawpixel, CC0
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Patients with a specific high-risk form of bowel cancer remained free of disease recurrence for almost three years after receiving a short course of immunotherapy before surgery, according to new findings from the NEOPRISM-CRC clinical trial. The results, led by researchers at University College London (UCL) and University College London Hospitals (UCLH), suggest this approach may offer more durable control than the standard combination of surgery and chemotherapy.

    The data is scheduled for presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026 in April. These latest findings extend earlier results from the same trial, which showed that nine weeks of treatment with the immunotherapy drug pembrolizumab caused significant tumor shrinkage in people with stage two or three bowel cancer.

    Zero Recurrence in High-Risk Patients

    Initial data from the trial indicated that 59% of patients had no detectable signs of disease after receiving pembrolizumab and undergoing their planned surgery. The latest follow-up data, covering 33 months, shows that none of the patients in the trial experienced a return of their cancer.

    This outcome held true for all participants, including those who still had small amounts of disease remaining after the initial treatment. In these cases, the residual cancer did not grow or spread during the follow-up period. This stands in sharp contrast to the standard treatment pathway, where approximately 25% of patients treated with surgery followed by chemotherapy are expected to relapse within three years.

    Laboratory Technologist Caren Cherotich (31
    Photo: Unknown / Rawpixel, CC0

    The trial enrolled 32 patients with stage two or three bowel cancer who had a particular genetic profile known as MMR deficient or MSI-high. This genetic makeup affects roughly 10% to 15% of people with stage two or three bowel cancer, equating to approximately 2,000 to 3,000 cases each year in the UK.

    Blood Tests Predict Treatment Response

    Researchers also analyzed blood samples to understand why the treatment was so effective and to identify biomarkers that could predict which patients would benefit most. They developed personalized blood tests designed to detect early signs of treatment success or the presence of circulating cancer traces.

    The study found that changes in tumor DNA in the bloodstream closely mirrored how well patients were responding to the therapy. The disappearance of tumor DNA from the blood was strongly associated with having no cancer remaining after surgery.

    Dr. Kai-Keen Shiu, Chief Investigator of the trial from the UCL Cancer Institute, emphasized the significance of these findings. He noted that seeing no cancer recurrence after nearly three years strengthens confidence in pembrolizumab as a safe and effective treatment for high-risk bowel cancers.

    Lab tube
    Photo: Unknown / Rawpixel, CC0

    “What is particularly exciting is that we now may be able to predict who will respond to the treatment using personalized blood tests and immune profiling,” Dr. Shiu said. “These tools could help us tailor our approach, identifying patients who are doing well and may need less therapy versus patients at higher risk of disease progression who need additional treatment.”

    Real-World Impact on Patient Outcomes

    The trial involved collaboration between UCL, UCLH, University Hospital Southampton, St. James’s University Hospital in Leeds, and The Christie NHS Foundation Trust in Manchester. Translational research was conducted by UCL and biotechnology company Personalis.

    Professor Marnix Jansen, a clinician scientist leading the translational research, stated that the results confirm the durability of responses seen earlier and provide biological insights into the effectiveness of immunotherapy in this setting.

    Christopher Burston, a 73-year-old patient from Portland, Dorset, participated in the trial after being diagnosed with stage three bowel cancer in February 2023. He received three doses of immunotherapy over nine weeks before undergoing surgery in May 2023. Burston reported few side effects and a smooth recovery.

    U.S. Army Spc. Erica Corley
    Photo: U.S. Forest Service (source) / Rawpixel, CC0

    “The outcome of the surgery was essentially that the cancer had melted away, these were the doctor’s words,” Burston said. “The immunotherapy had had an almost immediate effect.” More than three years later, he remains cancer-free and has returned to his normal activities.

    Bowel cancer is the fourth most common cancer in the UK, with roughly 44,000 new cases diagnosed annually. While outcomes are generally better when the disease is detected early, survival rates drop significantly for advanced stages. Five-year survival stands at 65% for stage three disease and just 10% for stage four.

    The ongoing trial continues to monitor participants to further validate these long-term outcomes and refine the use of personalized blood tests in clinical practice.

    Source: ScienceDaily

    bowel cancer cancer research Clinical Trial Health immunotherapy pembrolizumab UCL
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleKing Charles warns of evolving cyber threats in NCSC letter
    Next Article Avianca Flight Diverts to Miami After Severe Turbulence Injures 9
    im.news

    Related Posts

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 2026

    US Lawmakers Seek Stricter AI Chip Export Controls

    November 20, 2026

    TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

    November 20, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 20261 Views

    US Lawmakers Seek Stricter AI Chip Export Controls

    November 20, 20263 Views

    TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

    November 20, 20262 Views

    US, Mexico, Bolivia Lose Measles-Free Status as Global Cases Rise

    November 20, 20262 Views
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025 News Focus 247 Views

    In a stunning development that has sent shockwaves through political and entertainment circles, Attorney General…

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide the daily life news. You find latest trendy news at our portal, from entertainment to economy or politics.

    We're accepting new partnerships right now.

    Email Us: info@im.news

    Facebook X (Twitter) RSS
    Our Picks

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 2026

    US Lawmakers Seek Stricter AI Chip Export Controls

    November 20, 2026

    TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

    November 20, 2026
    Most Popular

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025247 Views

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025208 Views

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025165 Views
    © 2026 I'm News. Designed by I'm News.
    • Home
    • Lifestyle
    • Relations
    • Travel & Tourism
    • Technology

    Type above and press Enter to search. Press Esc to cancel.